Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells
Ha Ra Gu, Su Cheol Park, Su Jin Choi, Jae Cheol Lee, You Cheoul Kim, Chul Ju Han, Jin Kim, Ki Young Yang, Yeon Joo Kim, Geum Youb Noh, So Hyeon No, Jae-Hoon Jeong
Clin Mol Hepatol. 2015;21(1):49-59.   Published online 2015 Mar 25     DOI: https://doi.org/10.3350/cmh.2015.21.1.49
Citations to this article as recorded by Crossref logo
Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma
Jeong-Ju Yoo, Su Yu, Juri Na, Kyungmin Kim, Young Cho, Yun Lee, Eun Cho, Jeong-Hoon Lee, Yoon Kim, Hyewon Youn, Jung-Hwan Yoon
International Journal of Molecular Sciences.2019; 20(6): 1292.     CrossRef
Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines
Weixiao An, Honglin Lai, Yangyang Zhang, Minghua Liu, Xiukun Lin, Shousong Cao
Frontiers in Pharmacology.2019;[Epub]     CrossRef
Poly(glycerol methacrylate)-based degradable nanoparticles for delivery of small interfering RNA
Noha G. Morsi, Shimaa M. Ali, Sherouk S. Elsonbaty, Ahmed A. Afifi, Mostafa A. Hamad, Hui Gao, Mahmoud Elsabahy
Pharmaceutical Development and Technology.2018; 23(4): 387.     CrossRef
Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT
Jie Mao, Hongbao Yang, Tingting Cui, Pan Pan, Nadia Kabir, Duo Chen, Jinyan Ma, Xingyi Chen, Yijun Chen, Yong Yang
European Journal of Pharmacology.2018; 832: 39.     CrossRef
Milk thistle (Silybum marianum ): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases
Ludovico Abenavoli, Angelo A. Izzo, Natasa Milić, Carla Cicala, Antonello Santini, Raffaele Capasso
Phytotherapy Research.2018; 32(11): 2202.     CrossRef
A circRNA–miRNA–mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma
Dan-dan Xiong, Yi-wu Dang, Peng Lin, Dong-yue Wen, Rong-quan He, Dian-zhong Luo, Zhen-bo Feng, Gang Chen
Journal of Translational Medicine.2018;[Epub]     CrossRef
Silibinin induces hepatic stellate cell cycle arrest via enhancing p53/p27 and inhibiting Akt downstream signaling protein expression
Devaraj Ezhilarasan, Jonathan Evraerts, Brice Sid, Pedro Buc Calderon, Sivanesan Karthikeyan, Etienne Sokal, Mustapha Najimi
Hepatobiliary & Pancreatic Diseases International.2017; 16(1): 80.     CrossRef
Targeting STAT3 with silibinin to improve cancer therapeutics
Joaquim Bosch-Barrera, Bernardo Queralt, Javier A. Menendez
Cancer Treatment Reviews.2017; 58: 61.     CrossRef
FGF8 promotes cell proliferation and resistance to EGFR inhibitors via upregulation of EGFR in human hepatocellular carcinoma cells
Yuanmin Pei, Xueling Sun, Xiwei Guo, Huashan Yin, Le Wang, Fugu Tian, Hongxi Jing, Xiaobo Liang, Jun Xu, Pengcheng Shi
Oncology Reports.2017; 38(4): 2205.     CrossRef
Silibinin suppresses bladder cancer cell malignancy and chemoresistance in an NF-κB signal-dependent and signal-independent manner
Yi Sun, Zhenfeng Guan, Wencai Zhao, Yazhuo Jiang, Qing Li, Yongyi Cheng, Yonggang Xu
International Journal of Oncology.2017; 51(4): 1219.     CrossRef
Silibinin: a potential old drug for cancer therapy
Xing-Xing Zhu, Ya-Hui Ding, Yi Wu, Lin-Yan Qian, Hai Zou, Qiang He
Expert Review of Clinical Pharmacology.2016; 9(10): 1323.     CrossRef
Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14
Yuri Cho, Yun Bin Lee, Jeong-Hoon Lee, Dong Hyeon Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jong In Kim, Jong Hun Im, Jung Hwan Lee, Eun Ju Oh, Jung-Hwan Yoon, Seung Up Kim
PLOS ONE.2016; 11(8): e0160822.     CrossRef
Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma
Chen-Yi Liao, Ching-Chang Lee, Chi-chang Tsai, Chao-Wen Hsueh, Chih-Chiang Wang, I-Hung Chen, Ming-Kai Tsai, Mei-Yu Liu, An-Tie Hsieh, Kuan-Jen Su, Hau-Ming Wu, Shih-Chung Huang, Yi-Chen Wang, Chien-Yao Wang, Shu-Fang Huang, Yen-Cheng Yeh, Ren-Jy Ben, Sha
BioMed Research International.2015; 2015: 1.     CrossRef